Halozyme Therapeutics, Inc. HALO
$82.54
-0.91%
at last close
Financials (TTM)
- Revenue
- $1.51 billion
- Net Income
- $348.84 million
- Net Margin
- 23.13%
- Return on Equity
- 158.83%
- Debt-to-Equity
- —
- P/E Ratio
- 28.86
- Price / Book
- 44.58
- Price / Sales
- 6.49
Over the trailing twelve months, Halozyme Therapeutics, Inc. generated revenue of $1.51 billion and net income of $348.84 million, a net margin of 23.13%.
At the last closing price of $82.54, HALO trades at 28.86 times trailing earnings and 6.49 times sales, with a market capitalization of $9.79 billion.
Key Stats
- Last Close
- $82.54
- Market Cap
- $9.79 billion
- 52-Week Range
- $51.06 – $84.44
- Average Volume
- 1.90 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.